Publicacións en colaboración con investigadores/as de Instituto de Salud Carlos III (18)

2024

  1. Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6-7 Months of age: A Phase 1/2 Randomized Trial

    The Journal of infectious diseases, Vol. 229, Núm. 1, pp. 95-107

2023

  1. Bronchiolitis, Regardless of Its Etiology and Severity, Is Associated With Increased Risk of Asthma: A Population-Based Study

    The Journal of infectious diseases, Vol. 228, Núm. 7, pp. 840-850

  2. Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus (RSV) Vaccine in Healthy RSV-Seropositive Children 12-23 Months of Age

    The Journal of infectious diseases, Vol. 227, Núm. 11, pp. 1293-1302

2021

  1. Influenza vaccine effectiveness and waning effect in hospitalized older adults. Valencia region, Spain, 2018/2019 season

    International Journal of Environmental Research and Public Health, Vol. 18, Núm. 3, pp. 1-17

  2. Whole-genome analysis surveillance of influenza a virus resistance to polymerase complex inhibitors in Eastern Spain from 2016 to 2019

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 6

2019

  1. Influenza vaccine effectiveness against laboratory-confirmed influenza in hospitalised adults aged 60 years or older, Valencia Region, Spain, 2017/18 influenza season

    Eurosurveillance, Vol. 24, Núm. 31

2018

  1. Incidence rates of narcolepsy diagnoses in Taiwan, Canada, and Europe: The use of statistical simulation to evaluate methods for the rapid assessment of potential safety issues on a population level in the SOMNIA study

    PLoS ONE, Vol. 13, Núm. 10

  2. Influenza vaccine effectiveness in preventing hospitalisation of individuals 60 years of age and over with laboratory-confirmed influenza, Valencia Region, Spain, influenza season 2016/17

    Eurosurveillance, Vol. 23, Núm. 8

  3. Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines – Multi-country assessment

    Vaccine, Vol. 36, Núm. 41, pp. 6202-6211

2017

  1. Agent-based model to determine the evolution of the seroprotection against meningococal c over the next years

    Mathematical Research Summaries (Nova Science Publishers, Inc.), pp. 143-144

  2. Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season

    Vaccine, Vol. 35, Núm. 52, pp. 7331-7338

  3. Waning protection of influenza vaccination during four influenza seasons, 2011/2012 to 2014/2015

    Vaccine, Vol. 35, Núm. 43, pp. 5799-5807

2016

  1. Genetic characterization of influenza viruses from influenza-related hospital admissions in the St. Petersburg and Valencia sites of the Global Influenza Hospital Surveillance Network during the 2013/14 influenza season

    Journal of Clinical Virology, Vol. 84, pp. 32-38

2014

  1. Agent-Based Model to Determine the Evolution of the Seroprotection Against Meningococal C over the Next Years

    Mathematical Modeling in Social Sciences and Engineering (Nova Science Publishers, Inc.), pp. 281-290

  2. Optimizing strategies for meningococcal C disease vaccination in Valencia (Spain)

    BMC Infectious Diseases, Vol. 14, Núm. 1

2010

  1. Nosocomial rotavirus gastroenteritis in Spain: A multicenter prospective study

    Pediatric Infectious Disease Journal, Vol. 29, Núm. 1, pp. 23-27

1999

  1. Enfermedad invasora por Haemophilus influenzae tipo b en la Comunidad Valenciana

    Medicina Clinica, Vol. 112, Núm. 1, pp. 20-23

1998

  1. Vacunacion frente a Haemophilus influenzae tipo b en la comunidad Valenciana: Efectividad vacunal y fallos vacunales

    Anales Espanoles de Pediatria, Vol. 48, Núm. 4, pp. 352-354